Daily lung ultrasound to see if it shortens hospital stays for adults with acute decompensated heart failure

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study looks at whether daily lung ultrasound examinations, performed during hospitalization, can shorten length of stay and lower the rate of recurrent heart failure hospitalizations compared with standard care. Eligible participants are adults admitted with various forms of acute or acute-on-chronic heart failure to the Mayo Clinic in Rochester. The trial compares daily ultrasound-guided assessments to a blinded standard of care arm, focusing on hospitalization efficiency and outcomes. Lung ultrasound is the primary intervention, with consent and daily procedures required during the hospital stay.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subjects ≥18 years of age
* Admitted to St. Mary's Hospital Cardiology Progressive Care Unit (Cardiology 1-5 teams)
* Admission diagnosis of either:

  1. Acute systolic heart failure
  2. Acute on chronic systolic heart failure
  3. Acute diastolic heart failure
  4. Acute on chronic diastolic heart failure
  5. Acute right heart failure
  6. Acute on chronic right heart failure
  7. Failure heart biventricular
* Able to provide informed consent and willing to undergo daily lung ultrasound examinations during their hospitalization.

Exclusion Criteria:

* Subjects \<18 years of age
* Unable to provide informed consent.
* Unwilling to undergo daily lung ultrasound examinations.

Where it's running

• Mayo Clinic in Rochester
  Rochester, Minnesota, United States Recruiting

Study contacts

• Principal investigator: Jared Bird, MD — Mayo Clinic
• Study coordinator: Andy Dang
• Email: dang.phong@mayo.edu
• Phone: 507-255-7752

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating a noninvasive tissue sensor to detect cardiogenic shock earlier in heart patients

  This pilot, noninvasive study tests whether the NIRSense wearable can help detect deterioration in adults with cardiogenic shock risk due to heart attack or heart failure.

  Recruiting NIRSense Inc. · Weston, Florida · NCT07825363

• BEAT-SHOCK: Baseline Registry for Acute Cardiogenic Shock at Basel

  This registry collects and shares data on adults with cardiogenic shock admitted to University Hospital Basel to help understand how these patients are treated and how they fare.

  Recruiting University Hospital, Basel, Switzerland · Basel, Canton of Basel-City · NCT07643610

• Adding extra diuretics to standard care for acute decompensated heart failure

  This trial will test whether adding empagliflozin, acetazolamide, or metolazone to loop diuretics helps adults hospitalized with acute decompensated heart failure remove fluid and feel better.

  Recruiting Phase 2 Tanta University · Tanta · NCT07372040

• Acetazolamide versus metolazone added to usual diuretics for acute decompensated heart failure

  This trial will test whether adding acetazolamide or metolazone to standard diuretics works better and is safer for adults hospitalized with acute decompensated heart failure.

  Recruiting University of Health Sciences Lahore · Chak Eighty-seven -Twelve Left, Punjab Province · NCT07199088

• Fluid removal with the Reprieve System for acute decompensated heart failure

  This trial will test whether the Reprieve System removes excess fluid more effectively than standard IV diuretics in adults hospitalized with acute decompensated heart failure who are at risk for diuretic resistance.

  Recruiting at 49 sites Reprieve Cardiovascular, Inc · Irvine, California and 49 other locations · NCT06898515

• Using ultrasound to guide treatment for heart failure patients

  This study is testing if using ultrasound to guide treatment can help hospitalized heart failure patients feel better by managing fluid buildup in their bodies.

  Recruiting Oslo University Hospital · Oslo · NCT06714409

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.